• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

DYAX:US

9.0100 USD 0.2500 2.85%

As of 20:10:00 ET on 07/10/2014.

Company Profile for Dyax Corp (DYAX)

Dyax Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of antibodies, small proteins and peptides as therapeutic products for unmet medical needs, particularly in the areas of inflammation and oncology. The Company currently has two recombinant proteins, DX-88 and DX-890 in phase II clinical trials.

Contact Information

Dyax Corp

55 Network Drive
Burlington, MA 01803
United States
Phone: 1-617-225-2500
Fax: 1-617-225-2501

Key Executives for Dyax Corp (DYAX)

Gustav A ChristensenPresident/CEOGeorge V MigauskyExec VP/CFO
Burt A AdelmanExec VP/Chief Medical OfcrAndrew AsheExec VP/General Counsel
Nicole JonesDir:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil